SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-068490
Filing Date
2018-11-14
Accepted
2018-11-14 17:01:53
Documents
85
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19005_110q.htm 10-Q 990568
2 EX-4.1 a18-19005_1ex4d1.htm EX-4.1 10518
3 EX-10.2 a18-19005_1ex10d2.htm EX-10.2 150589
4 EX-31.1 a18-19005_1ex31d1.htm EX-31.1 10573
5 EX-31.2 a18-19005_1ex31d2.htm EX-31.2 10556
6 EX-32.1 a18-19005_1ex32d1.htm EX-32.1 5677
7 EX-32.2 a18-19005_1ex32d2.htm EX-32.2 6131
14 GRAPHIC g190051km01i001.jpg GRAPHIC 3020
15 GRAPHIC g190051km01i002.gif GRAPHIC 94
  Complete submission text file 0001104659-18-068490.txt   6549369

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ontx-20180930.xml EX-101.INS 1527293
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20180930.xsd EX-101.SCH 70339
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20180930_cal.xml EX-101.CAL 38043
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20180930_def.xml EX-101.DEF 233848
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20180930_lab.xml EX-101.LAB 500571
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20180930_pre.xml EX-101.PRE 406701
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 181184927
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1